Comments
Baxter Alzheimer's drug keeps four patients stable for 3 years
18.07.2012. | VANCOUVER (Reuters) - Four Alzheimer's patients treated with an immune system therapy have seen their disease stabilize for at least three years, raising hope that the drug from Baxter International Inc will prove effective in larger trials....
